Guidelines for chemotherapy of biliary tract and ampullary carcinomas View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-01

AUTHORS

Junji Furuse, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Hiroya Saito, Toshio Tsuyuguchi, Koichi Hirata, Fumio Kimura, Hideyuki Yoshitomi, Satoshi Nozawa, Masahiro Yoshida, Keita Wada, Hodaka Amano, Fumihiko Miura

ABSTRACT

Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment. More... »

PAGES

55-62

References to SciGraph publications

  • 2005-09-02. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1999-02. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma in INVESTIGATIONAL NEW DRUGS
  • 2008-01. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 2004-04. Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer in INVESTIGATIONAL NEW DRUGS
  • 2005-04-26. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer in BRITISH JOURNAL OF CANCER
  • 2004-03-16. A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer in BRITISH JOURNAL OF CANCER
  • 2002-09-23. Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial in BRITISH JOURNAL OF CANCER
  • 2004-04-13. Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract in BRITISH JOURNAL OF CANCER
  • 2008-01-23. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2002-12. CPT-11 for bile-duct and gallbladder carcinoma in JOURNAL OF GASTROINTESTINAL CANCER
  • 2002-08. Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas in INVESTIGATIONAL NEW DRUGS
  • 2004-10-26. Phase II study of S-1 in patients with advanced biliary tract cancer in BRITISH JOURNAL OF CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z

    DOI

    http://dx.doi.org/10.1007/s00534-007-1280-z

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1017686721

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18274844


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ampulla of Vater", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biliary Tract Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chemotherapy, Adjuvant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Evidence-Based Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division Kashiwa\u2010shi, Chiba Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division Kashiwa\u2010shi, Chiba Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Furuse", 
            "givenName": "Junji", 
            "id": "sg:person.01154650450.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154650450.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Teikyo University School of Medicine Department of Surgery Tokyo Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Teikyo University School of Medicine Department of Surgery Tokyo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Takada", 
            "givenName": "Tadahiro", 
            "id": "sg:person.01145073410.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145073410.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miyazaki", 
            "givenName": "Masaru", 
            "id": "sg:person.0773025611.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773025611.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Fujita Health University Department of Gastroenterological Surgery Toyoake Japan", 
              "id": "http://www.grid.ac/institutes/grid.256115.4", 
              "name": [
                "Fujita Health University Department of Gastroenterological Surgery Toyoake Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miyakawa", 
            "givenName": "Shuichi", 
            "id": "sg:person.012517244744.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012517244744.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toyama Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research Toyama Japan", 
              "id": "http://www.grid.ac/institutes/grid.267346.2", 
              "name": [
                "University of Toyama Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research Toyama Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tsukada", 
            "givenName": "Kazuhiro", 
            "id": "sg:person.01233146520.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233146520.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nagoya University Graduate School of Medicine Division of Surgical Oncology, Department of Surgery Nagoya Japan", 
              "id": "http://www.grid.ac/institutes/grid.27476.30", 
              "name": [
                "Nagoya University Graduate School of Medicine Division of Surgical Oncology, Department of Surgery Nagoya Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nagino", 
            "givenName": "Masato", 
            "id": "sg:person.01211606464.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211606464.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hokkaido University Graduate School of Medicine Department of Surgical Oncology Sapporo Japan", 
              "id": "http://www.grid.ac/institutes/grid.39158.36", 
              "name": [
                "Hokkaido University Graduate School of Medicine Department of Surgical Oncology Sapporo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kondo", 
            "givenName": "Satoshi", 
            "id": "sg:person.01264520473.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264520473.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Asahikawa Kosei General Hospital Department of Radiology Asahikawa Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Asahikawa Kosei General Hospital Department of Radiology Asahikawa Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Saito", 
            "givenName": "Hiroya", 
            "id": "sg:person.01245744760.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245744760.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chiba University Graduate School of Medicine Department of Medicine and Clinical Oncology Chiba Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Chiba University Graduate School of Medicine Department of Medicine and Clinical Oncology Chiba Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tsuyuguchi", 
            "givenName": "Toshio", 
            "id": "sg:person.0727433030.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727433030.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Sapporo Medical University School of Medicine Department of Surgical Oncology and Gastroenterological Surgery Sapporo Japan", 
              "id": "http://www.grid.ac/institutes/grid.263171.0", 
              "name": [
                "Sapporo Medical University School of Medicine Department of Surgical Oncology and Gastroenterological Surgery Sapporo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hirata", 
            "givenName": "Koichi", 
            "id": "sg:person.015313514313.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015313514313.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kimura", 
            "givenName": "Fumio", 
            "id": "sg:person.01127754745.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127754745.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yoshitomi", 
            "givenName": "Hideyuki", 
            "id": "sg:person.01245062664.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245062664.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nozawa", 
            "givenName": "Satoshi", 
            "id": "sg:person.01267524127.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267524127.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Teikyo University School of Medicine Department of Surgery Tokyo Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Teikyo University School of Medicine Department of Surgery Tokyo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yoshida", 
            "givenName": "Masahiro", 
            "id": "sg:person.01130041525.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130041525.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Teikyo University School of Medicine Department of Surgery Tokyo Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Teikyo University School of Medicine Department of Surgery Tokyo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wada", 
            "givenName": "Keita", 
            "id": "sg:person.01162577627.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162577627.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Teikyo University School of Medicine Department of Surgery Tokyo Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Teikyo University School of Medicine Department of Surgery Tokyo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Amano", 
            "givenName": "Hodaka", 
            "id": "sg:person.01167775323.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167775323.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Teikyo University School of Medicine Department of Surgery Tokyo Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Teikyo University School of Medicine Department of Surgery Tokyo Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miura", 
            "givenName": "Fumihiko", 
            "id": "sg:person.01115635730.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115635730.35"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00534-007-1274-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024299938", 
              "https://doi.org/10.1007/s00534-007-1274-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-005-0095-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030889660", 
              "https://doi.org/10.1007/s00280-005-0095-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1385/ijgc:32:2-3:107", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038909402", 
              "https://doi.org/10.1385/ijgc:32:2-3:107"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:drug.0000011797.09549.53", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038864503", 
              "https://doi.org/10.1023/b:drug.0000011797.09549.53"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1016209901417", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015634355", 
              "https://doi.org/10.1023/a:1016209901417"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602576", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052616134", 
              "https://doi.org/10.1038/sj.bjc.6602576"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602208", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015354465", 
              "https://doi.org/10.1038/sj.bjc.6602208"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-007-0673-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013512506", 
              "https://doi.org/10.1007/s00280-007-0673-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6601736", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016846770", 
              "https://doi.org/10.1038/sj.bjc.6601736"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1006268018519", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035563235", 
              "https://doi.org/10.1023/a:1006268018519"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600543", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016551013", 
              "https://doi.org/10.1038/sj.bjc.6600543"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6601796", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008635604", 
              "https://doi.org/10.1038/sj.bjc.6601796"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2008-01", 
        "datePublishedReg": "2008-01-01", 
        "description": "Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00534-007-1280-z", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1043285", 
            "issn": [
              "1868-6974", 
              "1868-6982"
            ], 
            "name": "Journal of Hepato-Biliary-Pancreatic Sciences", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "15"
          }
        ], 
        "keywords": [
          "biliary tract cancer", 
          "unresectable biliary tract cancer", 
          "tract cancer", 
          "clinical trials", 
          "tegafur/gimeracil/oteracil potassium", 
          "multi-institutional RCTs", 
          "best supportive care", 
          "postoperative adjuvant chemotherapy", 
          "good general condition", 
          "benefit of chemotherapy", 
          "effective adjuvant therapy", 
          "use of gemcitabine", 
          "further clinical trials", 
          "quality of life", 
          "unresectable disease", 
          "biliary decompression", 
          "oteracil potassium", 
          "adjuvant chemotherapy", 
          "chemotherapy group", 
          "advanced disease", 
          "adjuvant therapy", 
          "standard chemotherapy", 
          "supportive care", 
          "performance status", 
          "distant metastasis", 
          "biliary tract", 
          "ampullary carcinoma", 
          "standard treatment", 
          "histopathological diagnosis", 
          "pathological diagnosis", 
          "novel agents", 
          "chemotherapy", 
          "patients", 
          "control group", 
          "cancer", 
          "significant treatment", 
          "diagnosis", 
          "trials", 
          "appropriate use", 
          "RCTs", 
          "gemcitabine", 
          "disease", 
          "care", 
          "treatment", 
          "general condition", 
          "general deterioration", 
          "guidelines", 
          "resection", 
          "previous studies", 
          "recurrence", 
          "carcinoma", 
          "group", 
          "metastasis", 
          "therapy", 
          "cytology", 
          "tract", 
          "decompression", 
          "survival", 
          "status", 
          "great care", 
          "agents", 
          "use", 
          "deterioration", 
          "present time", 
          "study", 
          "life", 
          "benefits", 
          "potassium", 
          "date", 
          "large number", 
          "quality", 
          "number", 
          "time", 
          "choice", 
          "conditions", 
          "article", 
          "order", 
          "rules"
        ], 
        "name": "Guidelines for chemotherapy of biliary tract and ampullary carcinomas", 
        "pagination": "55-62", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1017686721"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00534-007-1280-z"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18274844"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00534-007-1280-z", 
          "https://app.dimensions.ai/details/publication/pub.1017686721"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:25", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_467.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00534-007-1280-z"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'


     

    This table displays all metadata directly associated to this object as RDF triples.

    357 TRIPLES      22 PREDICATES      124 URIs      104 LITERALS      15 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00534-007-1280-z schema:about N2df9411da06847a1910e282f269287ee
    2 N45a36b645f904999ab8799f94c445202
    3 N46a5ac88751346a59f2a89c28cdd471c
    4 N47e2a21f71a049bdb22b754467a17a9e
    5 N67b42afd226946c3b4ae1bdc57f3f40f
    6 Nc69a970aee1f45fe8223c3ceca8874f8
    7 Ne524ee9984e444048824614a1f09113a
    8 Ned547a85b0d447d7849f8f614ccd82ae
    9 anzsrc-for:11
    10 anzsrc-for:1112
    11 schema:author N3555b3744ab741a49110d193bcdd6b2d
    12 schema:citation sg:pub.10.1007/s00280-005-0095-3
    13 sg:pub.10.1007/s00280-007-0673-7
    14 sg:pub.10.1007/s00534-007-1274-x
    15 sg:pub.10.1023/a:1006268018519
    16 sg:pub.10.1023/a:1016209901417
    17 sg:pub.10.1023/b:drug.0000011797.09549.53
    18 sg:pub.10.1038/sj.bjc.6600543
    19 sg:pub.10.1038/sj.bjc.6601736
    20 sg:pub.10.1038/sj.bjc.6601796
    21 sg:pub.10.1038/sj.bjc.6602208
    22 sg:pub.10.1038/sj.bjc.6602576
    23 sg:pub.10.1385/ijgc:32:2-3:107
    24 schema:datePublished 2008-01
    25 schema:datePublishedReg 2008-01-01
    26 schema:description Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment.
    27 schema:genre article
    28 schema:inLanguage en
    29 schema:isAccessibleForFree true
    30 schema:isPartOf N105aee97a10442b6af68dfc6b2ab1b2a
    31 N1229517d2e2d4392820e1cb521ac8f60
    32 sg:journal.1043285
    33 schema:keywords RCTs
    34 adjuvant chemotherapy
    35 adjuvant therapy
    36 advanced disease
    37 agents
    38 ampullary carcinoma
    39 appropriate use
    40 article
    41 benefit of chemotherapy
    42 benefits
    43 best supportive care
    44 biliary decompression
    45 biliary tract
    46 biliary tract cancer
    47 cancer
    48 carcinoma
    49 care
    50 chemotherapy
    51 chemotherapy group
    52 choice
    53 clinical trials
    54 conditions
    55 control group
    56 cytology
    57 date
    58 decompression
    59 deterioration
    60 diagnosis
    61 disease
    62 distant metastasis
    63 effective adjuvant therapy
    64 further clinical trials
    65 gemcitabine
    66 general condition
    67 general deterioration
    68 good general condition
    69 great care
    70 group
    71 guidelines
    72 histopathological diagnosis
    73 large number
    74 life
    75 metastasis
    76 multi-institutional RCTs
    77 novel agents
    78 number
    79 order
    80 oteracil potassium
    81 pathological diagnosis
    82 patients
    83 performance status
    84 postoperative adjuvant chemotherapy
    85 potassium
    86 present time
    87 previous studies
    88 quality
    89 quality of life
    90 recurrence
    91 resection
    92 rules
    93 significant treatment
    94 standard chemotherapy
    95 standard treatment
    96 status
    97 study
    98 supportive care
    99 survival
    100 tegafur/gimeracil/oteracil potassium
    101 therapy
    102 time
    103 tract
    104 tract cancer
    105 treatment
    106 trials
    107 unresectable biliary tract cancer
    108 unresectable disease
    109 use
    110 use of gemcitabine
    111 schema:name Guidelines for chemotherapy of biliary tract and ampullary carcinomas
    112 schema:pagination 55-62
    113 schema:productId Nbc93cf98d1094269872e8c53c113906c
    114 Nc4afd1196081404881e155a141b96e30
    115 Ncc839b968d2b46248e27bdf5350e32a8
    116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017686721
    117 https://doi.org/10.1007/s00534-007-1280-z
    118 schema:sdDatePublished 2022-05-20T07:25
    119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    120 schema:sdPublisher Nca6621eefb374c5699cc3212ca6fe160
    121 schema:url https://doi.org/10.1007/s00534-007-1280-z
    122 sgo:license sg:explorer/license/
    123 sgo:sdDataset articles
    124 rdf:type schema:ScholarlyArticle
    125 N0bfd486e90db4966ac838f61a74abe57 rdf:first sg:person.01245744760.47
    126 rdf:rest N74b7301c9c764d93aa7d71a9370dc60c
    127 N0d19b2f551394e14bb949810fa605d2b rdf:first sg:person.01233146520.29
    128 rdf:rest N53d6469160014bd0ac68c05ca5767856
    129 N105aee97a10442b6af68dfc6b2ab1b2a schema:issueNumber 1
    130 rdf:type schema:PublicationIssue
    131 N1229517d2e2d4392820e1cb521ac8f60 schema:volumeNumber 15
    132 rdf:type schema:PublicationVolume
    133 N12a5104c7c3c4ee980840bb435fe5142 rdf:first sg:person.0773025611.35
    134 rdf:rest N24541279de5e4d41864f2b4323f999c4
    135 N24541279de5e4d41864f2b4323f999c4 rdf:first sg:person.012517244744.16
    136 rdf:rest N0d19b2f551394e14bb949810fa605d2b
    137 N2df9411da06847a1910e282f269287ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Antineoplastic Agents
    139 rdf:type schema:DefinedTerm
    140 N33ec69940cad4a54990e32fb9af58d5f rdf:first sg:person.01167775323.13
    141 rdf:rest Nd4b7700a8a4044d7b2bbeeb55e5f1c04
    142 N3555b3744ab741a49110d193bcdd6b2d rdf:first sg:person.01154650450.78
    143 rdf:rest N75cade7baa4a4d6ba69f5da49b729a2c
    144 N45a36b645f904999ab8799f94c445202 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Chemotherapy, Adjuvant
    146 rdf:type schema:DefinedTerm
    147 N46a5ac88751346a59f2a89c28cdd471c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Biliary Tract Neoplasms
    149 rdf:type schema:DefinedTerm
    150 N47e2a21f71a049bdb22b754467a17a9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Randomized Controlled Trials as Topic
    152 rdf:type schema:DefinedTerm
    153 N53d6469160014bd0ac68c05ca5767856 rdf:first sg:person.01211606464.55
    154 rdf:rest N6d84f4bbbe4c4a09a612a6ddd76e3021
    155 N58bac3cfd6934371b4cd2881dc14bc55 rdf:first sg:person.01245062664.63
    156 rdf:rest Ne5b2a3de760b4fe98036a9b82e031130
    157 N5aa6a54ce423451ca5bed2abcf2f54aa rdf:first sg:person.01127754745.32
    158 rdf:rest N58bac3cfd6934371b4cd2881dc14bc55
    159 N67b42afd226946c3b4ae1bdc57f3f40f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Humans
    161 rdf:type schema:DefinedTerm
    162 N6d84f4bbbe4c4a09a612a6ddd76e3021 rdf:first sg:person.01264520473.17
    163 rdf:rest N0bfd486e90db4966ac838f61a74abe57
    164 N74b7301c9c764d93aa7d71a9370dc60c rdf:first sg:person.0727433030.42
    165 rdf:rest Nee15fe61dd644e39ac41b68d3ba5c829
    166 N75cade7baa4a4d6ba69f5da49b729a2c rdf:first sg:person.01145073410.03
    167 rdf:rest N12a5104c7c3c4ee980840bb435fe5142
    168 Nbc93cf98d1094269872e8c53c113906c schema:name pubmed_id
    169 schema:value 18274844
    170 rdf:type schema:PropertyValue
    171 Nc4afd1196081404881e155a141b96e30 schema:name dimensions_id
    172 schema:value pub.1017686721
    173 rdf:type schema:PropertyValue
    174 Nc69a970aee1f45fe8223c3ceca8874f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Evidence-Based Medicine
    176 rdf:type schema:DefinedTerm
    177 Nca6621eefb374c5699cc3212ca6fe160 schema:name Springer Nature - SN SciGraph project
    178 rdf:type schema:Organization
    179 Ncc839b968d2b46248e27bdf5350e32a8 schema:name doi
    180 schema:value 10.1007/s00534-007-1280-z
    181 rdf:type schema:PropertyValue
    182 Nd4b7700a8a4044d7b2bbeeb55e5f1c04 rdf:first sg:person.01115635730.35
    183 rdf:rest rdf:nil
    184 Ndfd3258e8884446eacc94cb59727dc6e rdf:first sg:person.01162577627.41
    185 rdf:rest N33ec69940cad4a54990e32fb9af58d5f
    186 Ne524ee9984e444048824614a1f09113a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Ampulla of Vater
    188 rdf:type schema:DefinedTerm
    189 Ne5b2a3de760b4fe98036a9b82e031130 rdf:first sg:person.01267524127.30
    190 rdf:rest Nf615b4bed6ae4af1b0666f4480d40847
    191 Ned547a85b0d447d7849f8f614ccd82ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Carcinoma
    193 rdf:type schema:DefinedTerm
    194 Nee15fe61dd644e39ac41b68d3ba5c829 rdf:first sg:person.015313514313.07
    195 rdf:rest N5aa6a54ce423451ca5bed2abcf2f54aa
    196 Nf615b4bed6ae4af1b0666f4480d40847 rdf:first sg:person.01130041525.07
    197 rdf:rest Ndfd3258e8884446eacc94cb59727dc6e
    198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    199 schema:name Medical and Health Sciences
    200 rdf:type schema:DefinedTerm
    201 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    202 schema:name Oncology and Carcinogenesis
    203 rdf:type schema:DefinedTerm
    204 sg:journal.1043285 schema:issn 1868-6974
    205 1868-6982
    206 schema:name Journal of Hepato-Biliary-Pancreatic Sciences
    207 schema:publisher Springer Nature
    208 rdf:type schema:Periodical
    209 sg:person.01115635730.35 schema:affiliation grid-institutes:grid.264706.1
    210 schema:familyName Miura
    211 schema:givenName Fumihiko
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115635730.35
    213 rdf:type schema:Person
    214 sg:person.01127754745.32 schema:affiliation grid-institutes:grid.136304.3
    215 schema:familyName Kimura
    216 schema:givenName Fumio
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127754745.32
    218 rdf:type schema:Person
    219 sg:person.01130041525.07 schema:affiliation grid-institutes:grid.264706.1
    220 schema:familyName Yoshida
    221 schema:givenName Masahiro
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130041525.07
    223 rdf:type schema:Person
    224 sg:person.01145073410.03 schema:affiliation grid-institutes:grid.264706.1
    225 schema:familyName Takada
    226 schema:givenName Tadahiro
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145073410.03
    228 rdf:type schema:Person
    229 sg:person.01154650450.78 schema:affiliation grid-institutes:None
    230 schema:familyName Furuse
    231 schema:givenName Junji
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154650450.78
    233 rdf:type schema:Person
    234 sg:person.01162577627.41 schema:affiliation grid-institutes:grid.264706.1
    235 schema:familyName Wada
    236 schema:givenName Keita
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162577627.41
    238 rdf:type schema:Person
    239 sg:person.01167775323.13 schema:affiliation grid-institutes:grid.264706.1
    240 schema:familyName Amano
    241 schema:givenName Hodaka
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167775323.13
    243 rdf:type schema:Person
    244 sg:person.01211606464.55 schema:affiliation grid-institutes:grid.27476.30
    245 schema:familyName Nagino
    246 schema:givenName Masato
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211606464.55
    248 rdf:type schema:Person
    249 sg:person.01233146520.29 schema:affiliation grid-institutes:grid.267346.2
    250 schema:familyName Tsukada
    251 schema:givenName Kazuhiro
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233146520.29
    253 rdf:type schema:Person
    254 sg:person.01245062664.63 schema:affiliation grid-institutes:grid.136304.3
    255 schema:familyName Yoshitomi
    256 schema:givenName Hideyuki
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245062664.63
    258 rdf:type schema:Person
    259 sg:person.01245744760.47 schema:affiliation grid-institutes:None
    260 schema:familyName Saito
    261 schema:givenName Hiroya
    262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245744760.47
    263 rdf:type schema:Person
    264 sg:person.012517244744.16 schema:affiliation grid-institutes:grid.256115.4
    265 schema:familyName Miyakawa
    266 schema:givenName Shuichi
    267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012517244744.16
    268 rdf:type schema:Person
    269 sg:person.01264520473.17 schema:affiliation grid-institutes:grid.39158.36
    270 schema:familyName Kondo
    271 schema:givenName Satoshi
    272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264520473.17
    273 rdf:type schema:Person
    274 sg:person.01267524127.30 schema:affiliation grid-institutes:grid.136304.3
    275 schema:familyName Nozawa
    276 schema:givenName Satoshi
    277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267524127.30
    278 rdf:type schema:Person
    279 sg:person.015313514313.07 schema:affiliation grid-institutes:grid.263171.0
    280 schema:familyName Hirata
    281 schema:givenName Koichi
    282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015313514313.07
    283 rdf:type schema:Person
    284 sg:person.0727433030.42 schema:affiliation grid-institutes:grid.136304.3
    285 schema:familyName Tsuyuguchi
    286 schema:givenName Toshio
    287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727433030.42
    288 rdf:type schema:Person
    289 sg:person.0773025611.35 schema:affiliation grid-institutes:grid.136304.3
    290 schema:familyName Miyazaki
    291 schema:givenName Masaru
    292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773025611.35
    293 rdf:type schema:Person
    294 sg:pub.10.1007/s00280-005-0095-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030889660
    295 https://doi.org/10.1007/s00280-005-0095-3
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1007/s00280-007-0673-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013512506
    298 https://doi.org/10.1007/s00280-007-0673-7
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1007/s00534-007-1274-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024299938
    301 https://doi.org/10.1007/s00534-007-1274-x
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1023/a:1006268018519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035563235
    304 https://doi.org/10.1023/a:1006268018519
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1023/a:1016209901417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015634355
    307 https://doi.org/10.1023/a:1016209901417
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1023/b:drug.0000011797.09549.53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038864503
    310 https://doi.org/10.1023/b:drug.0000011797.09549.53
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1038/sj.bjc.6600543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016551013
    313 https://doi.org/10.1038/sj.bjc.6600543
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/sj.bjc.6601736 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016846770
    316 https://doi.org/10.1038/sj.bjc.6601736
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1038/sj.bjc.6601796 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008635604
    319 https://doi.org/10.1038/sj.bjc.6601796
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1038/sj.bjc.6602208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015354465
    322 https://doi.org/10.1038/sj.bjc.6602208
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1038/sj.bjc.6602576 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052616134
    325 https://doi.org/10.1038/sj.bjc.6602576
    326 rdf:type schema:CreativeWork
    327 sg:pub.10.1385/ijgc:32:2-3:107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038909402
    328 https://doi.org/10.1385/ijgc:32:2-3:107
    329 rdf:type schema:CreativeWork
    330 grid-institutes:None schema:alternateName Asahikawa Kosei General Hospital Department of Radiology Asahikawa Japan
    331 National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division Kashiwa‐shi, Chiba Japan
    332 schema:name Asahikawa Kosei General Hospital Department of Radiology Asahikawa Japan
    333 National Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division Kashiwa‐shi, Chiba Japan
    334 rdf:type schema:Organization
    335 grid-institutes:grid.136304.3 schema:alternateName Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan
    336 Chiba University Graduate School of Medicine Department of Medicine and Clinical Oncology Chiba Japan
    337 schema:name Chiba University Graduate School of Medicine Department of General Surgery Chiba Japan
    338 Chiba University Graduate School of Medicine Department of Medicine and Clinical Oncology Chiba Japan
    339 rdf:type schema:Organization
    340 grid-institutes:grid.256115.4 schema:alternateName Fujita Health University Department of Gastroenterological Surgery Toyoake Japan
    341 schema:name Fujita Health University Department of Gastroenterological Surgery Toyoake Japan
    342 rdf:type schema:Organization
    343 grid-institutes:grid.263171.0 schema:alternateName Sapporo Medical University School of Medicine Department of Surgical Oncology and Gastroenterological Surgery Sapporo Japan
    344 schema:name Sapporo Medical University School of Medicine Department of Surgical Oncology and Gastroenterological Surgery Sapporo Japan
    345 rdf:type schema:Organization
    346 grid-institutes:grid.264706.1 schema:alternateName Teikyo University School of Medicine Department of Surgery Tokyo Japan
    347 schema:name Teikyo University School of Medicine Department of Surgery Tokyo Japan
    348 rdf:type schema:Organization
    349 grid-institutes:grid.267346.2 schema:alternateName University of Toyama Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research Toyama Japan
    350 schema:name University of Toyama Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research Toyama Japan
    351 rdf:type schema:Organization
    352 grid-institutes:grid.27476.30 schema:alternateName Nagoya University Graduate School of Medicine Division of Surgical Oncology, Department of Surgery Nagoya Japan
    353 schema:name Nagoya University Graduate School of Medicine Division of Surgical Oncology, Department of Surgery Nagoya Japan
    354 rdf:type schema:Organization
    355 grid-institutes:grid.39158.36 schema:alternateName Hokkaido University Graduate School of Medicine Department of Surgical Oncology Sapporo Japan
    356 schema:name Hokkaido University Graduate School of Medicine Department of Surgical Oncology Sapporo Japan
    357 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...